A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.
Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.
A specific group of fungi residing in the intestines can protect against intestinal injury and influence social behavior, according to new preclinical research by scientists at Weill Cornell Medicine.
New York Gov. Kathy Hochul outlined plans for rebuilding the state’s infrastructure Feb. 10 at a New York City event sponsored by Cornell’s Institute of Politics and Global Affairs.
Vaccination Conversations with Scientists, a group of more than 100 Cornell scientist volunteers educating the public about vaccines, is reporting success in shifting unvaccinated people’s beliefs about the shots.
An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury in severe COVID-19 cases, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.
Gov. Kathy Hochul will describe her vision for the state’s infrastructure in a New York City conversation sponsored by the Cornell Brooks School’s Institute of Politics and Global Affairs.
Scientists at Weill Cornell Medicine have developed a pipeline that will enable study of the biological roles of gut bacteria, recognized as key factors in health and disease.
A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease, according to a new discovery from Weill Cornell Medicine researchers.
